Back 5 new Ph. Eur. reference standard and 13 replacement batches released in May 2024

EDQM Strasbourg, France 04/06/2024
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF
5 new Ph. Eur. reference standard and 13 replacement batches released in May 2024

See also:

The European Directorate for the Quality of Medicines & HealthCare (EDQM) announces the release of:

 

5 new European Pharmacopoeia (Ph. Eur.) reference standards:

Catalogue code

Name

Unit quantity

Price

Y0002469

Polysorbate 80 CRS

100 mg

79 EUR

Y0002444

Erlotinib hydrochloride CRS

150 mg

150 EUR

Y0002464

Polysorbate 20 CRS

100 mg

79 EUR

Y0002467

Polysorbate 40 CRS

100 mg

79 EUR

Y0002468

Polysorbate 60 CRS

100 mg

79 EUR


13 replacement batches for Ph. Eur. reference standards:

Catalogue code

Name

Batch

Unit quantity

Price

M1755000

Methylprednisolone acetate CRS

3

110 mg

79 EUR

Y0000372

Thiamazole impurity A CRS

2

50 mg

79 EUR

H0190000

Heparin Low-Molecular-Mass for calibration CRS

6

10 mg

170 EUR

Y0001111

Ceftazidime for peak identification CRS

5

13 mg

79 EUR

Y0001804

Gadobutrol for peak identification CRS

4

20 mg

79 EUR

Y0000054

Alprostadil CRS

4

25 mg

79 EUR

Y0000556

Febantel CRS

4

120 mg

79 EUR

Y0000675

Gemcitabine hydrochloride CRS

3

60 mg

79 EUR

Y0000349

Insulin aspart CRS

6

8 mg

90 EUR

Y0000550

Sulbactam for peak identification CRS

3

20 mg

79 EUR

Z2000010

Zinc acexamate impurity A CRS

2

50 mg

79 EUR

E0300000

Ephedrine hydrochloride CRS - * Drug Precursor

4

160 mg

79 EUR

Y0000095

Diosmin for system suitability CRS

4

15 mg

79 EUR


Distribution quota

Information on distribution quota for Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP (Y0001689)

Due to premature depletion of stocks of the Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP (cat. # Y0001689), we wish to inform users that a tight distribution quota has been established.

This BRP will be distributed to plasma-derived therapeutic product manufacturers and Official Medicines Control Laboratories only, with a maximum of 1 unit per month. This quota may be adjusted according to availability.

This exceptional measure will remain in place until the next batch of this BRP is established, which is expected by the end of 2024.

Distribution of the Immunoglobulin for anti-A, anti-B antibodies limit test BRP (cat. # Y0001153) and the Immunoglobulin (anti-A, anti-B antibodies test Positive control) BRP (cat. # Y0001688) is not affected by this measure.

We apologise for any inconvenience caused and thank you for your understanding.


Information on reference standards removed from catalogue

Supplement 11.3

Following the implementation of Supplement 11.3, the following standards are officially withdrawn (or replaced) from 1 January 2024.

Y0002166

Donepezil Hydrochloride Monohydrate

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1 July 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1 January 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

Y0000679

Mepyramine impurity A

Y0001288

Salbutamol sulfate for system suitability (replaced by Salbutamol for peak identification CRS Y0002386)

Y0000030

Salbutamol impurity B

Y0000071

Salbutamol impurity D

Y0000031

Salbutamol impurity F

Y0000034

Salbutamol impurity G

Y0000032

Salbutamol impurity I

Y0000371

Sestamibi labelling kit (replaced by Sestamibi labelling kit A CRS Y0002420)

Y0000115

Sotalol impurity B

T2200010

Trimethoprim impurity B

Y0000684

Trimethoprim for system suitability (replaced by Trimethoprim for peak identification CRS Y0002392)


Information on reference standards with a future removal from catalogue

Additional removal from catalogue

Catalogue code

Name

 

I0305000

Insulin (bovine) CRS

This reference standard will be officially withdrawn from sale on 30/06/2024. The reference will remain visible in the catalogue until 31/12/2024.


Supplement 11.4

Following the implementation of Supplement 11.4, the following standards will be officially withdrawn (or replaced) from 1st April 2024.

S2400004

Suxibuzone impurity B CRS

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1st October 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1st April 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

T0040000

Temazepam CRS - * psy

Y0000346

Temazepam impurity F CRS

Y0000344

Temazepam impurity C CRS

Y0000345

Temazepam impurity D CRS

Y0000347

Temazepam impurity G CRS

Y0002071

Calcium folinate for system suitability CRS (replaced by calcium folinate for system suitability A CRS)

 

Supplement 11.5

Following the implementation of Supplement 11.5, the following standard will be officially withdrawn (or replaced) from 1st July 2024.

C2320000

Clomifene citrate CRS

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1st January 2025. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1st July 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.


Change of sales units

The sales unit of Esculin CRS (Y0001612) has been changed from 1 to 2 units. The quantity per vial is sufficient to perform the test mentioned in Ph. Eur. monograph 2452 and 2945.


Information on change of amount per unit

  • Thiamazole impurity A CRS (Y0000372) batch 2 contains 50 mg per unit (15 mg previously)
  • Febantel CRS (Y0000556) batch 4 contains 120 mg per unit (150 mg previously)
  • Gemcitabine hydrochloride CRS (Y0000675) batch 3 contains 60 mg per unit (50 mg previously)
  • Ephedrine hydrochloride CRS - * Drug Precursor (E0300000) batch 4 contains 160 mg per unit (150 mg previously)
  • Diosmin for system suitability CRS (Y0000095) batch 4 contains 15 mg per unit (10 mg previously)

Information on change of price

None


Information on change of EDQM storage/shipping conditions

Based on new stability information, storage and shipping conditions has been changed on 15 May 2024 for the following reference standard:

  • Heparin LMM for calibration CRS (H0190000) batch 6 is stored at -20°C (previously +5°C) and shipped on ice at -20°C (previously +5°C).
  • Betacarotene CRS (Y0002050) batch 4 is stored at -20°C (previously +5°C) and shipped on ice at -20°C (previously ambiant).
  • Betacarotene for system suitability CRS (Y0002073) batch 1 is stored at -20°C (previously +5°C) and shipped on ice at -20°C (previously ambiant).

Based on new stability information, storage and shipping conditions will change on 15 June 2024 for the following reference standard:

  • Captopril impurity J CRS (Y0001450) batch 3 will be stored at -20°C (currently +5°C) and remain shipped at ambient temperature.

Information on International Chemical Reference Substances (ICRS) and International Standards for Antibiotics (ISA)

ICRS

  • None

ISA

  • None

Rules about Substances depleting the ozone layer

Regulation (EU) 2024/590 on substances that deplete the ozone layer entered into force on 11 March 2024. The rules governing the placing on the market and use of ozone-depleting substances for essential laboratory and analytical uses have now changed.

Under the new regulation, standards shipped to a location within the European Union no longer need to be registered in the labODS registry.

There is no change to the procedure for shipments outside the European Union.

The EDQM Reference Standards affected by this change are:

R0250000

Class 1 residual solvent solution CRS

T1985000

Trichlorotrifluoroethane CRS

Important notes:

In all cases, these Reference Standards supplied by the EDQM must be used exclusively for essential laboratory and analytical uses (i.e. for analytical uses in conjunction with the texts published in the European Pharmacopoeia).

We would also like to draw your attention to the obligations of users affected by this change that are described under Article 8(4) of this regulation.


Content of the European Pharmacopoeia RS catalogue

The EDQM proposes more than 3 100 Ph. Eur. RS including a wide range of highly characterised chemical reference substances (CRS), herbal reference standards (HRS) and biological reference preparations (BRP), as well as reference spectra for the tests and assays to be carried out in accordance with the official methods prescribed in the Ph. Eur.

The Ph. Eur. RS catalogue is updated on a daily basis and gives access not only to all the Ph. Eur. RS, but also to:

  • batch validity statements (BVSs) for each reference standard;
  • Safety Data Sheets and Safety Data Statements for hazardous biologicals;
  • leaflets (downloadable PDFs).

For your convenience, the Ph. Eur. RS catalogue is published daily and can be downloaded in in PDF format and in XML format.

When stocks of a given reference standard are low, the EDQM reserves the right to limit the quantities sold to each user to ensure that as many users as possible will receive at least some of the quantities available. Restrictions on quantities are applied at the time the purchase order is received.

Following a request from many users, the quantities allowed in case of sales restrictions now appear in the online catalogue as well as in the catalogue in XML format.

The EDQM is also responsible for the establishment, preparation, storage and distribution of WHO International Chemical Reference Standards (ICRS) and International Standards for Antibiotics (ISA).


How to place an RS order

If you wish to place an order, you can send your request to the EDQM either:

  • via the WebStore;
  • or by e-mail to [email protected] (in this case, please ensure that your order, on your company letterhead, states both the catalogue code and substance name and is attached to your e-mail).

A video has been prepared to help user ordering through the RS WebStore.


The EDQM helps the users to test some draft texts proposed in Pharmeuropa through Qualified Samples

In some cases, ‘qualified samples’ are made available by the EDQM at the time of publication in Pharmeuropa to allow users to check the changes (e.g. to the related substances test) proposed during the public enquiry and best prepare for the implementation of the monograph.

Where a qualified sample is available, it is described in the briefing note of the Pharmeuropa monograph and may be ordered free of charge by raising a request in the EDQM HelpDesk.

After use, users are kindly requested to share their results with the EDQM.

To place an order via the EDQM HelpDesk, please click on European Pharmacopoeia and choose the category Question about General Chapters and Monographs. Providing us with your full shipping address and the title of the corresponding Ph. Eur. monograph, while stating ‘Qualified sample’ in the subject of the query, will help us to rapidly process your request.

For further information on how to use the EDQM HelpDesk, please see the HelpDesk User Manual.